Initial data suggests that both vaccinated and recovered patients have been infected in South Africa. “There is very little data as not much is coming from South Africa,” Lutsar admitted. “It is likely we will get more information from the outbreak in Norway.”
Commenting on hospitalizations spiking in RSA, Lutsar said that in addition to the age and complaints of patients, it would be useful to know their PCR testing cycle thresholds. A lower count indirectly indicates a greater quantity of the virus in the person’s system.
However, Lutsar said that the reference base was very low in South Africa, which is characteristic to the appearance of new strains. “New strains always develop where the virus is not widespread,” the virologist said, adding that were the infection rate as low in Estonia as it is in South Africa, it wouldn’t even make the news.
It is too soon to predict what Omicron will do in Europe that is currently in the throes of the Delta variant of the virus.
Lutsar said that Omicron includes mutations that are associated with faster spread and the ability to dodge vaccines but added that the virus being able to ignore vaccines altogether seems very unlikely. “A high antibody count should still help prevent illness,” she said.